Alliance Foundation Trials, Llc.

This study tested if adding two newer drugs (apalutamide and abiraterone) to standard hormone therapy could better control prostate cancer that came back after surgery. It involved 504 men with rapidly rising PSA levels. The main goal was to see how long it took for PSA to rise a…

This early-phase study tested a three-drug combination (ibrutinib, lenalidomide, and dexamethasone) in 14 people whose multiple myeloma had returned or stopped responding to treatment. The main goal was to find safe doses and identify side effects. While the approach aims to cont…